We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
+6.38%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$37.1B
AUM Growth
+$1.81B
(+5.1%)
Cap. Flow
-$137M
Cap. Flow
% of AUM
-0.37%
Top 10 Holdings %
Top 10 Hldgs %
8.75%
Holding
2,506
New
326
Increased
944
Reduced
921
Closed
286
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PG&E
PCG
|
+$297M |
| 2 |
CELG
Celgene Corp
CELG
|
+$277M |
| 3 |
US Bancorp
USB
|
+$190M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$154M |
| 5 |
ExxonMobil
XOM
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$259M |
| 2 |
DuPont de Nemours
DD
|
+$255M |
| 3 |
Boeing
BA
|
+$243M |
| 4 |
Altria Group
MO
|
+$234M |
| 5 |
Union Pacific
UNP
|
+$228M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.5% |
| 2 | Technology | 15.03% |
| 3 | Consumer Discretionary | 14.19% |
| 4 | Industrials | 12.34% |
| 5 | Consumer Staples | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KRA
1001
DELISTED
Kraton Corporation
KRA
| $3.38M | 0.01% |
+70,191
| New | +$3.25M |
|
1002
Rapid7
RPD
$634M
| $3.38M | 0.01% |
181,000
+71,800
| +66% | +$1.33M |
|
1003
iShares Russell 1000 ETF
IWB
$47.7B
| $3.37M | 0.01% |
22,700
-24,000
| -51% | -$3.48M |
|
|
CEO
1004
DELISTED
CNOOC Limited
CEO
| $3.36M | 0.01% |
23,400
-36,700
| -61% | -$4.97M |
|
1005
LG Display
LPL
$3.17B
| $3.35M | 0.01% |
243,600
+41,700
| +21% | +$561K |
|
1006
Citi Trends
CTRN
$524M
| $3.34M | 0.01% |
126,122
+38,900
| +45% | +$907K |
|
1007
AMERISAFE
AMSF
$569M
| $3.33M | 0.01% |
54,082
-10,200
| -16% | -$641K |
|
1008
MGM Resorts International
MGM
$11.7B
| $3.33M | 0.01% |
+99,747
| New | +$3.21M |
|
|
INAP
1009
DELISTED
Internap Corporation
INAP
| $3.33M | 0.01% |
+212,008
| New | +$3.6M |
|
1010
Pan American Silver
PAAS
$18.6B
| $3.33M | 0.01% |
213,810
+120,924
| +130% | +$1.92M |
|
|
NXGN
1011
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $3.33M | 0.01% |
245,036
-20,748
| -8% | -$298K |
|
1012
Murphy USA
MUSA
$11.3B
| $3.33M | 0.01% |
+41,400
| New | +$3.13M |
|
1013
Liberty Global Class A
LBTYA
$3.31B
| $3.32M | 0.01% |
92,650
-7,893
| -8% | -$251K |
|
|
GTLS
1014
DELISTED
Chart Industries
GTLS
| $3.32M | 0.01% |
70,821
-91,000
| -56% | -$4.06M |
|
1015
AAR Corp
AIR
$5.15B
| $3.31M | 0.01% |
84,373
-6,800
| -7% | -$274K |
|
1016
Corpay
CPAY
$24.2B
| $3.31M | 0.01% |
+17,195
| New | +$3.02M |
|
1017
Ezcorp Inc
EZPW
$1.82B
| $3.3M | 0.01% |
270,617
+85,000
| +46% | +$928K |
|
|
AFI
1018
DELISTED
Armstrong Flooring, Inc.
AFI
| $3.3M | 0.01% |
194,900
-47,714
| -20% | -$773K |
|
1019
Axogen
AXGN
$2.1B
| $3.3M | 0.01% |
116,500
+44,600
| +62% | +$1.05M |
|
|
CLVS
1020
DELISTED
Clovis Oncology, Inc.
CLVS
| $3.29M | 0.01% |
+48,400
| New | +$3.38M |
|
1021
MidCap Financial Investment
MFIC
$784M
| $3.29M | 0.01% |
193,721
+130,848
| +208% | +$2.35M |
|
1022
PennantPark Floating Rate Capital
PFLT
$681M
| $3.29M | 0.01% |
239,446
+29,600
| +14% | +$417K |
|
|
SCG
1023
DELISTED
Scana
SCG
| $3.28M | 0.01% |
82,521
+74,971
| +993% | +$3.35M |
|
|
VIVO
1024
DELISTED
Meridian Bioscience Inc
VIVO
| $3.27M | 0.01% |
233,741
+5,900
| +3% | +$86.4K |
|
|
SVC
1025
Service Properties Trust
SVC
$1.1B
| $3.27M | 0.01% |
21,901
+11,940
| +120% | +$1.75M |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q4 2017 Portfolio in Review
As of Q4 2017, Two Sigma Advisers held 2,506 positions worth $37.1B, up 5.1% from $35.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
Two Sigma Advisers's Q4 2017 filing shows 326 new, 944 increased, 921 reduced and 286 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 381,038 shares worth $143M. The largest sale was Chevron, an estimated $259M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 14% a quarter earlier, followed by Technology and Consumer Discretionary.
- Two Sigma Advisers's largest Q4 2017 buy was Regeneron Pharmaceuticals: 381,038 shares worth $143M.
- Two Sigma Advisers added most to PG&E in Q4 2017, an estimated $297M increase.
- Two Sigma Advisers's biggest Q4 2017 reduction was Chevron, cutting an estimated $259M.
- Two Sigma Advisers fully exited DuPont de Nemours in Q4 2017, selling an estimated $255M.
- Two Sigma Advisers's ten largest holdings make up 8.7% of its $37.1B portfolio in Q4 2017.
- Two Sigma Advisers opened 326 new positions and closed 286 in Q4 2017.
- Two Sigma Advisers's portfolio value rose 5.1% quarter-over-quarter to $37.1B.
Based on Two Sigma Advisers's 13F filing for Q4 2017, filed 14 Feb 2018.